000			01212naa a2200217uu 4500
001			8274
003			OSt
005			20190211154423.0
008			021112s2005 xx ||||gr |0|| 0 eng d
100	1		_aAFUAH, Allan _917345
245	1	0	_aMapping technological capabilities into product markets and competitive advantage : _bthe case of cholesterol drugs
260			_c2002
520	3		_aWhile a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how he model can be used to estimate customer value and competitive advantage from technological capabilities
650		4	_aTechnological Capabilities _917346
650		4	_aCompetitive Advantage _916454
650		4	_aHedonics _917347
773	0	8	_tStrategic Management Journal _g23, 2, p. 171-179 _d, 2002 _w
942			_cS
998			_a20021112 _bLucima _cLucimara
998			_a20060612 _b1629^b _cQuiteria
999			_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c8420 _d8420
041			_aeng